Seattle Genetics Reports Q4 Earnings Results

Seattle Genetics Reports Q4 Earnings Results

Source: 
Motley Fool
snippet: 

Seattle Genetics (NASDAQ: SGEN) reported its fourth-quarter and 2019 full-year financial results this afternoon. Revenue for Q4 came in at $289.8 million, a substantial increase from the $174.5 million reported for Q4 2018. While net product sales have gone up noticeably, royalty and license agreements revenues have seen exponential growth as well, with both having almost tripled over the past 12 months.